Literature DB >> 14769200

About the evaluation of drug combination.

Zheng-jun Jin.   

Abstract

Mesh：

Year:  2004        PMID： 14769200

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  26 in total

1.  Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation.

Authors:  Zhen-Dong Shi; Xiao-Min Qian; Chao-Yong Liu; Lei Han; Kai-Liang Zhang; Lu-Yue Chen; Jun-Xia Zhang; Pei-Yu Pu; Xu-Bo Yuan; Chun-Sheng Kang
Journal:  CNS Neurosci Ther       Date:  2012-12-11       Impact factor: 5.243

2.  Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.

Authors:  Wen Shang; Ping Han; Cheng-bing Yang; Xiao-wen Gu; Wei Zhang; Li-ping Xu; Shou-ting Fu; Ding-feng Su; He-hui Xie
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

3.  MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.

Authors:  Yu Ren; Xuan Zhou; Mei Mei; Xu-Bo Yuan; Lei Han; Guang-Xiu Wang; Zhi-Fan Jia; Peng Xu; Pei-Yu Pu; Chun-Sheng Kang
Journal:  BMC Cancer       Date:  2010-01-31       Impact factor: 4.430

4.  A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.

Authors:  Xiaonan Ji; Yanli Shen; Hao Sun; Xiangdong Gao
Journal:  Tumour Biol       Date:  2016-01-28

5.  Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.

Authors:  Jing-Yan Cao; Li Liu; Shu-Peng Chen; Xing Zhang; Yan-Jun Mi; Zhi-Gang Liu; Man-Zhi Li; Hua Zhang; Chao-Nan Qian; Jian-Yong Shao; Li-Wu Fu; Yun-Fei Xia; Mu-Sheng Zeng
Journal:  Mol Cancer       Date:  2010-09-09       Impact factor: 27.401

6.  Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.

Authors:  Lirui Zhang; Xiaofeng Yang; Xu Li; Chen Li; Le Zhao; Yuanyuan Zhou; Huilian Hou
Journal:  Int J Mol Med       Date:  2015-08-24       Impact factor: 4.101

7.  ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib.

Authors:  Jiani Liu; Jiangxue Wu; Ling Zhou; Changchuan Pan; Yi Zhou; Wuying Du; Jie-Min Chen; Xiaofeng Zhu; Jingnan Shen; Shuai Chen; Ran-Yi Liu; Wenlin Huang
Journal:  Oncotarget       Date:  2015-08-28

8.  Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.

Authors:  Li-xia Li; Yan-ling Zhang; Ling Zhou; Miao-la Ke; Jie-min Chen; Xiang Fu; Chun-ling Ye; Jiang-xue Wu; Ran-yi Liu; Wenlin Huang
Journal:  J Transl Med       Date:  2013-10-14       Impact factor: 5.531

9.  Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract.

Authors:  Jie Wu; Xue Li; Hua Fang; Yanqun Yi; Dan Chen; Yan Long; Xinxin Gao; Xiaoyong Wei; C-Y Oliver Chen
Journal:  BMC Complement Altern Med       Date:  2016-08-12       Impact factor: 3.659

10.  Tanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communication.

Authors:  Jianyong Xiao; Guangxian Zhang; Pengxiang Qiu; Xijuan Liu; Yingya Wu; Biaoyan Du; Jiefen Li; Jing Zhou; Jingjing Li; Yuhui Tan
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.